Celltech Group plc Announces Interim Report for the Six Months Ended 30 June 2003
August 19, 2003 02:04 ET
|
Celltech Group plc
Slough, UK, August 19, 2003 (PRIMEZONE) -- Celltech Group plc (LSE:CCH) (NYSE:CLL) Interim Report for the Six Months Ended 30 June 2003
As a leading European biotechnology company with a strong...
Celltech Group plc: US Food and Drug Administration Approves Zavesca -- First Oral Treatment Option for Type 1 Gaucher Disease
August 01, 2003 04:37 ET
|
Celltech Group plc
SLOUGH, U.K., August 1, 2003 (PRIMEZONE) -- Celltech Group plc (LSE:CCH) (NYSE:CLL) and Actelion Ltd (SWX:ATLN) today announced that the US Food and Drug Administration (FDA) has approved Zavesca(R)...
Celltech Group plc: Celltech Announces Long-Term Microbial Manufacturing Agreement with Lonza
July 14, 2003 03:12 ET
|
Celltech Group plc
SLOUGH, England, July 13, 2003 (PRIMEZONE) -- Celltech Group plc (NYSE:CLL) (LSE:CCH) announced today that it has entered into a long-term supply agreement with Lonza Biotec, a division of Lonza...